Biogen Pharmachem Industries Limited (BOM:531752)

BOM:531752 Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	3.65	20.16	0.17	1.29	0.83	0.07
Cash & Short-Term Investments	3.65	20.16	0.17	1.29	0.83	0.07
Cash Growth	13.04%	11830.77%	-86.87%	54.69%	1018.46%	122.17%
Accounts Receivable	-	-	-	-	-	25.4
Other Receivables	-	5.67	-	-	18.4	-
Receivables	0.85	5.67	-	-	18.4	25.4
Other Current Assets	18.6	0.85	0.75	0.25	0.11	0.11
Total Current Assets	23.1	26.69	0.92	1.54	19.34	25.58
Long-Term Investments	213.71	238.44	54.43	88.53	69.53	94.92
Other Long-Term Assets	-	-0	-	-	-	-
Total Assets	991.75	920.18	568.22	548.28	549.5	542.51
Short-Term Debt	-	-	-	-	-	0.61
Other Current Liabilities	0.94	0.9	3.02	2.38	8.15	0.47
Total Current Liabilities	0.94	0.9	3.02	2.38	8.15	1.08
Total Liabilities	0.94	0.9	3.02	2.38	8.15	1.08
Common Stock	902.6	652.6	652.6	652.6	652.6	652.6
Retained Earnings	88.21	-90.33	-87.4	-106.71	-111.26	-111.18
Comprehensive Income & Other	-	357	-	-	-	-
Shareholders' Equity	990.81	919.28	565.2	545.9	541.34	541.43
Total Liabilities & Equity	991.75	920.18	568.22	548.28	549.5	542.51
Total Debt	-	-	-	-	-	0.61
Net Cash (Debt)	3.65	20.16	0.17	1.29	0.83	-0.53
Net Cash Growth	13.04%	11830.77%	-86.87%	54.69%	-	-
Net Cash Per Share	0.00	0.03	0.00	0.00	0.00	-0.00
Filing Date Shares Outstanding	491.5	652.6	652.6	652.6	652.6	652.6
Total Common Shares Outstanding	491.5	652.6	652.6	652.6	652.6	652.6
Working Capital	22.16	25.79	-2.1	-0.84	11.19	24.5
Book Value Per Share	2.02	1.41	0.87	0.84	0.83	0.83
Tangible Book Value	990.81	919.28	565.2	545.9	541.34	541.43
Tangible Book Value Per Share	2.02	1.41	0.87	0.84	0.83	0.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.